2021
DOI: 10.1158/1538-7445.sabcs20-pd11-03
|View full text |Cite
|
Sign up to set email alerts
|

Abstract PD11-03: Assessing the impact of 12 months lifestyle interventions on breast cancer secondary prevention: A modeling approach

Abstract: Background Healthy lifestyle, including caloric restriction, balanced diet and physical activity, is important in primary and secondary prevention of breast cancer (BC). It is known that Mediterranean diet reduces metabolic syndrome and insulin resistance that are associated with increased risk of BC onset and recurrence. Physical activity decreases BMI, blood concentrations of testosterone, estrogens, insulin, its resistance and strengthens anti-inflammatory pathways against tumor cells. Since January 2014, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
1
1
0
Order By: Relevance
“…Briefly, participant inclusion criteria were: ≤12-month post-surgery and post chemo- or radio-therapy adjuvant; stage 0 to III BC without metastases or recurrences diagnosis at recruitment in follow-up; aged 30–70 years; non-physically active (i.e., not engaged in at least 60 min/week of structured exercise during the previous 6 months); with a risk factor for recurrence. As reported in previous studies [ 39 , 40 , 41 , 42 ], the risk factors for recurrence were: body mass index (BMI) at diagnosis ≥25 kg/m 2 , testosterone ≥0.4 ng/mL; serum insulin ≥25 µU/mL (170 pmol/L); metabolic syndrome (at least 3 of the following 5 factors): a, glycemia ≥100 mg/dL (6.05 mmol/L); b, triglycerides ≥150 mg/dL (1.69 mmol L); c, HDL-C <50 mg/dL (1.29 mmol/L); d, waist circumference ≥80; e, blood pressure ≥130/85 mmHg. Exclusion criteria were: disabling pneumological, cardiological, neurological, orthopedic comorbidities, or mental illnesses that prevent the exercise performance; treatment with beta blockers, non-dihydropyridine calcium channel blockers, or amiodarone due to their potential effect on heart rate response to exercise; treatment with antidepressant drugs.…”
Section: Methodssupporting
confidence: 72%
“…Briefly, participant inclusion criteria were: ≤12-month post-surgery and post chemo- or radio-therapy adjuvant; stage 0 to III BC without metastases or recurrences diagnosis at recruitment in follow-up; aged 30–70 years; non-physically active (i.e., not engaged in at least 60 min/week of structured exercise during the previous 6 months); with a risk factor for recurrence. As reported in previous studies [ 39 , 40 , 41 , 42 ], the risk factors for recurrence were: body mass index (BMI) at diagnosis ≥25 kg/m 2 , testosterone ≥0.4 ng/mL; serum insulin ≥25 µU/mL (170 pmol/L); metabolic syndrome (at least 3 of the following 5 factors): a, glycemia ≥100 mg/dL (6.05 mmol/L); b, triglycerides ≥150 mg/dL (1.69 mmol L); c, HDL-C <50 mg/dL (1.29 mmol/L); d, waist circumference ≥80; e, blood pressure ≥130/85 mmHg. Exclusion criteria were: disabling pneumological, cardiological, neurological, orthopedic comorbidities, or mental illnesses that prevent the exercise performance; treatment with beta blockers, non-dihydropyridine calcium channel blockers, or amiodarone due to their potential effect on heart rate response to exercise; treatment with antidepressant drugs.…”
Section: Methodssupporting
confidence: 72%
“…Recruitment details are described in Natalucci et al 3 . Briefly, inclusion criteria were: ≤ 12 months post-surgery and post chemo- or radio-therapy adjuvant; stage 0 to III BC without metastases or recurrences diagnosis at recruitment; aged 30–70 years; non-physically active (i.e., not engaged in regular activity according to the International Physical Activity Questionnaire Short Form (IPAQ-SF) 17 , 18 for at least 6 months; with a high risk of recurrence 19 , 20 . Exclusion criteria were: disabling pneumatological, cardiological, neurological, orthopedic comorbidities, or mental illnesses that prevent exercise performance; treatment with beta-blockers, non-dihydropyridine calcium channel blockers, or amiodarone due to their potential effect on heart rate response to exercise; treatment with antidepressant drugs.…”
Section: Methodsmentioning
confidence: 99%